Abstract
Staphylococcus aureus produces phenol-soluble modulins (PSMs), which are amphipathic small peptides with lytic activity against mammalian cells. We previously reported that PSMα1–4 stimulate S. aureus colony spreading, the phenomenon of S. aureus colony expansion on the surface of soft agar plates, whereas δ-toxin (Hld, PSMγ) inhibits colony-spreading activity. In this study, we revealed the underlying mechanism of the opposing effects of PSMα1–4 and δ-toxin in S. aureus colony spreading. PSMα1–4 and δ-toxin are abundant on the S. aureus cell surface, and account for 18% and 8.5% of the total amount of PSMα1–4 and δ-toxin, respectively, in S. aureus overnight cultures. Knockout of PSMα1–4 did not affect the amount of cell surface δ-toxin. In contrast, knockout of δ-toxin increased the amount of cell surface PSMα1–4, and decreased the amount of culture supernatant PSMα1–4. The δ-toxin inhibited PSMα3 and PSMα2 binding to the S. aureus cell surface in vitro. A double knockout strain of PSMα1–4 and δ-toxin exhibited decreased colony spreading compared with the parent strain. Expression of cell surface PSMα1–4, but not culture supernatant PSMα1–4, restored the colony-spreading activity of the PSMα1-4/δ-toxin double knockout strain. Expression of δ-toxin on the cell surface or in the culture supernatant did not restore the colony-spreading activity of the PSMα1-4/δ-toxin double knockout strain. These findings suggest that cell surface PSMα1–4 promote S. aureus colony spreading, whereas δ-toxin suppresses colony-spreading activity by inhibiting PSMα1–4 binding to the S. aureus cell surface.
Introduction
Staphylococcus aureus is a human pathogenic bacterium that causes various human diseases, including suppurative diseases, pneumonia, and meningitis. Since the 1960s, methicillin-resistant S. aureus (MRSA) infection of immunocompromised patients in hospitals, i.e., hospital-associated MRSA (HA-MRSA), has become a serious clinical problem. Community-acquired MRSA (CA-MRSA), a new type of MRSA that infects healthy persons in the community, was identified as a serious health issue in the mid 1990s [1]. CA-MRSA is more virulent than HA-MRSA and produces abundant exotoxins, including phenol-soluble modulins (PSMs) [2]. PSMs comprise PSMα1, PSMα2, PSMα3, PSMα4, PSMβ1, PSMβ2, and δ-toxin (PSMγ), which are small polypeptides with an amphipathic alpha helical structure [3]. Among these PSMs, PSMα1, PSMα2, PSMα3, and δ-toxin have high lytic activity against neutrophils and erythrocytes [2]. In addition, PSMs have various functions, such as immune activation [4, 5], antimicrobial activity [6, 7], and promotion of biofilm formation [8]. Knockout of PSMα1–4 (PSMα1, PSMα2, PSMα3, and PSMα4) or δ-toxin decreases S. aureus virulence in a mouse infection model [2]. Clarifying PSM functions is important toward understanding the S. aureus infectious process at the molecular level.
Because S. aureus lacks flagella machinery, it was thought to be non-motile. We previously demonstrated, however, that S. aureus forms a giant colony on soft agar surfaces, reaching a diameter of ~60 mm after 10 h incubation at 37°C—a phenomenon we termed “colony spreading” [9]. CA-MRSA strains exhibit greater colony-spreading ability than most HA-MRSA strains [10]. A subgroup of HA-MRSA strains exhibits high colony-spreading ability and increased exotoxin production [11, 12]. The colony-spreading ability of S. aureus is positively regulated by the agr locus, which regulates the expression of various exotoxins and adhesion proteins [13, 14]. Furthermore, S. aureus colony spreading is stimulated by supplementing soft agar medium with mammalian serum [15] and is also observed on fresh pork meat [16]. These findings support the notion that the colony-spreading activity of S. aureus is involved in its virulence.
We previously reported that knockout of PSMα1–4 decreases colony-spreading activity [17], whereas knockout of δ-toxin increases S. aureus colony spreading [18]. The underlying mechanism for the opposing roles of PSMα1–4 and δ-toxin in S. aureus colony spreading, however, is not known. In the present study, we revealed the presence of PSMα1–4 and δ-toxin on the S. aureus cell surface and found that δ-toxin inhibited colony-spreading activity by decreasing the amounts of PSMα1–4 on the cell surface. The findings of the present study revealed a novel function of cell surface PSMs to modulate S. aureus colony spreading.
Materials and Methods
Bacterial strains and culture conditions
S. aureus Newman strain and its mutants were aerobically cultured in tryptic soy broth (TSB, Becton, Dickinson and Co., Franklin Lakes, NJ) at 37°C. When culturing S. aureus strains carrying plasmids, kanamycin (50 μg/ml) or chloramphenicol (12.5 μg/ml) were added to the medium. The Escherichia coli JM109 strain was used as host for pND50K and its derivatives. E. coli strains transformed with plasmids were aerobically cultured in Luria-Bertani broth containing 50 μg/ml kanamycin. Details of bacterial strains and plasmids used in this study are summarized in Table 1.
Table 1. Bacterial strains and plasmids used in the study.
Strain or plasmid | Genotypes or characteristics | Source or Ref. |
---|---|---|
S. aureus strains | ||
Newman | Laboratory strain, High level of clumping factor | [33] |
RN4220 | 8325–4, restriction mutant, partially agr suppressed | [34] |
YS1 | Newman Δpsmα::ermAM | [17] |
MN1844 | Newman Δagr::tetM (transduction from RN6911) | [13] |
MN1844WH | Newman hld-wild-type strain (MN1844 integrated with pW) | [18] |
MN1844H1 | Newman Δhld1 (MN1844 integrated with pH1) | [18] |
MN1844H2 | Newman Δhld2 (MN1844 integrated with pH2) | [18] |
DKO1 | Newman Δpsmα::ermAM, Δagr::tetM | This study |
DKO1H1 | Newman Δpsmα/Δhld1 (DKO1 integrated with pH1) | This study |
CK3 | RN4220 Δagr::tetM (transduction from RN6911) | [35] |
M1844WH | RN4220 hld-wild-type strain (CK3 integrated with pCK-W) | This study |
M1844H1 | RN4220 Δhld1 (CK3 integrated with pCK-H1) | This study |
M1844H2 | RN4220 Δhld2 (CK3 integrated with pCK-H2) | This study |
SA564 | A clinical isolate | [36] |
MS1844WH | SA564 hld-wild-type strain (transduction from M1844WH) | This study |
MS1844H1 | SA564 Δhld1 (transduction from M1844H1) | This study |
MS1844H2 | SA564 Δhld2 (transduction from M1844H2) | This study |
FRP3757 | CA-MRSA, USA300 | [37] |
MF1844WH | FRP3757 hld-wild-type strain (transduction from M1844WH) | This study |
MF1844H1 | FRP3757 Δhld1 (transduction from M1844H1) | This study |
MF1844H2 | FRP3757 Δhld2 (transduction from M1844H2) | This study |
MW2 | CA-MRSA, USA400 | [38] |
CA04 | CA-MRSA | [39] |
CA05 | CA-MRSA | [39] |
CA07 | CA-MRSA | [39] |
CA10 | CA-MRSA | [39] |
CA11 | CA-MRSA | [39] |
CA12 | CA-MRSA | [39] |
4/16-6N | CA-MRSA | [39] |
4/16-11A | CA-MRSA | [39] |
5/6-8N | CA-MRSA | [39] |
6/11-IN | CA-MRSA | [39] |
6/20-IN | CA-MRSA | [39] |
8/6-3P | CA-MRSA | [39] |
NI-1~NI-18 | Clinical isolates, methicillin resistant | [10] |
NI-20~NI-31 | Clinical isolates, methicillin resistant | [10] |
NI-33~NI-42 | Clinical isolates, methicillin resistant | [10] |
E. coli | ||
JM109 | General purpose host strain for cloning | Takara Bio |
Plasmids | ||
pCK20 | S. aureus integration vector; Cmr | [40] |
pCK-W | pCK20 with agr region from Newman | This study |
pCK-H1 | pCK20 with agr with an insertion mutation in hld (Δhld1) | This study |
pCK-H2 | pCK20 with agr with a deletion mutation in hld (Δhld2) | This study |
pInt | Integration vector into SA0083-84 intergenic region; Cmr | [18] |
pW | pInt with agr region from Newman | [18] |
pH1 | pInt with agr with an insertion mutation in hld (Δhld1) | [18] |
pH2 | pInt with agr with a deletion mutation in hld (Δhld2) | [18] |
pND50K | E. coli-S. aureus shuttle vector; Kanr | [17] |
pND50K-gmkP-luc | pND50K with gmk promoter and luc+ RBS-ORF | This study |
pND50K-αP-luc | pND50K with psmα promoter and luc+ RBS-ORF | This study |
pSP-PSMα1 | pND50K with psmα promoter and psmα1 RBS-ORF | This study |
pSP-PSMα2 | pND50K with psmα promoter and psmα2 RBS-ORF | This study |
pSP-PSMα3 | pND50K with psmα promoter and psmα3 RBS-ORF | This study |
pSP-PSMα4 | pND50K with psmα promoter and psmα4 RBS-ORF | This study |
pSP-PSMα1–4 | pND50K with psmα promoter and psmα1–4 RBS-ORF | [17] |
pSP-δ-toxin | pND50K with psmα promoter, psmα3 RBS, and hld ORF | This study |
pWP-PSMα1 | pND50K with gmk promoter and psmα1 RBS-ORF | This study |
pWP-PSMα2 | pND50K with gmk promoter and psmα2 RBS-ORF | This study |
pWP-PSMα3 | pND50K with gmk promoter and psmα3 RBS-ORF | This study |
pWP-PSMα4 | pND50K with gmk promoter and psmα4 RBS-ORF | This study |
pWP-PSMα1–4 | pND50K with gmk promoter and psmα1–4 RBS-ORF | This study |
pWP-δ-toxin | pND50K with gmk promoter and hld RBS-ORF | This study |
Cm, chloramphenicol; Kan, kanamycin.
PSM
PSMα2, PSMα3, and δ-toxin were chemically synthesized by CS Bio Corporation (Menlo Park, CA). PSMα1 and PSMα4 were chemically synthesized by Bio-Synthesis Corporation (Lewisville, TX). The N-terminus of all PSMs used in this study was formylated. HPLC analysis revealed that these peptides were more than 95% pure.
Measurement of cell surface PSMs or culture supernatant PSMs
S. aureus overnight culture (50 μl) was inoculated into 5 ml of fresh TSB and aerobically cultured for 19 h at 37°C. To measure cell surface PSMs, the culture was centrifuged at 2300g for 20 min, and the precipitated bacterial cells were suspended in 300 μl of 6 M guanidine HCl. The suspension was vortexed for 10 min and centrifuged at 20,400g for 5 min. The centrifuged supernatant was dried with a centrifuge evaporator (CC-105, TOMY, Tokyo, Japan or VC-96R, TAITEC, Saitama, Japan) and solved in 1 ml of 40% acetonitrile. The sample was vortexed for 10 min and centrifuged at 20,400g for 5 min. Eight hundred microliters of the centrifuged supernatant was dried with a centrifuge evaporator and solved in 300 μl of milliQ water. The sample was centrifuged at 20,400g for 5 min and 100 μl of the centrifuged supernatant was analyzed by HPLC.
To measure the culture supernatant PSMs, 19-h cultures were centrifuged at 2300g for 20 min and 2 ml of the supernatants was dried with a centrifuge evaporator. The dried sample was solved in 1 ml of 40% acetonitrile and vortexed for 10 min. The sample was centrifuged at 20,400g for 5 min and 800 μl of the supernatant was dried with a centrifuge evaporator. The dried precipitate was solved in 300 μl or 600 μl of 6 M guanidine HCl and vortexed for 10 min. The sample was centrifuged at 20,400g for 5 min and 100 μl of the supernatant was analyzed by HPLC.
HPLC analysis was performed using the previously described method [19] or a new method established in this study. In the previous method, PSMα1 and δ-toxin were not separated. In the new method, chromatography was performed using SOURCE 5RPC ST 4.6/150 (GE Healthcare, Tokyo, Japan) and 50% acetonitrile containing 0.1% trifluoroacetic acid for 32 min and a water/acetonitrile gradient in 0.1% trifluoroacetic acid from 50% to 90% acetonitrile for 18 min at a flow rate of 1 ml/min. Absorbance at 215 nm was detected using a photodiode array detector. The respective PSM peaks were confirmed using S. aureus strains that produce only one of the PSM species. Chemically synthesized PSM was serially diluted and analyzed by HPLC, and the calibration curve between the PSM amount (μg, dry weight) and peak area (μV⋅seconds) was calculated. PSM amount was determined according to the calibration curve.
PSM binding assay to the S. aureus cell surface
A single colony of the PSMα1-4/δ-toxin double knockout strain (DKO1H1) transformed with pND50K was cultured in 5 ml TSB containing 12.5 μg/ml chloramphenicol for 20–24 h. The culture was centrifuged at 2300g for 20 min and the precipitated cells were suspended in 1 ml of milliQ water. The suspension was vortexed for 10 min and centrifuged at 20,400g for 2 min. The precipitated cells were suspended in 1 ml milliQ water, vortexed for 5 min, and used for the binding assay. Chemically synthesized PSM was solved in milliQ water and used for the binding assay. The bacterial suspension (20 μl) and PSM solution (60 μl) were mixed and incubated for 30 min at 37°C. The sample was centrifuged at 20,400g for 10 min and the precipitated cells were suspended in 6 M guanidine HCl. The sample was vortexed for 10 min and centrifuged at 20,400g for 10 min. The supernatant was analyzed by HPLC and the amount of PSM was calculated according to the calibration curve. For the competition assay, PSMα2 and δ-toxin or PSMα3 and δ-toxin was mixed and added to the bacterial suspension.
Construction of S. aureus strains producing different amounts of PSM
To construct S. aureus strains producing high amounts of PSM, the coding sequences of PSM were placed under the promoter region of the psmα operon in pND50K (Table 1). First, the DNA fragment containing the psmα operon was amplified by PCR using oligonucleotide primers psma-C-F and psma-C-R (Table 2) and Newman genome DNA as a template, and inserted into pND50K, resulting in pSP-PSMα1–4. To obtain pSP-PSMα1, pSP-PSMα4, pSP-PSMα1–3, and pSP-PSMα2–4, the DNA fragments were amplified by PCR using the indicated primers (Table 2) and pSP-PSMα1–4 as a template, and self-ligated. To obtain pSP-PSMα2 or pSP-PSMα3, the DNA fragment was amplified by PCR using the indicated primers (Table 2) and pSP-PSMα1–3 or pSP-PSMα2–4 as a template, and self-ligated. To obtain pSP-δ-toxin, the coding sequence of psmα3 in pSP-PSMα3 was replaced with an hld sequence by PCR using primers a-Hld-F and a-Hld-R (Table 2).
Table 2. PCR primers used in the study.
Target or purpose | Primer | Sequence (5'-3') | |
---|---|---|---|
psmα operon | psma-C-F | GGAGGATCCAGACACTGCATCACGGTACG | [17] |
psma-C-R | GGTGGTACCGGCAAATTAGACCAGCACGA | [17] | |
Deletion of psmα1 | psmA1-D-F | CATAACAAACAAAGGAGGTCTTTCAC | This study |
psmA1-D-R | CCTCCTTTGCTTATGAGTTAACTTC | This study | |
Deletion of psmα2 | psmA2-D-F | CACTGGTAAGTAAGTTATAAAAATCTCATA | This study |
psmA2-D-R | GTGAAAGACCTCCTTTGTTTGTTATG | This study | |
Deletion of psmα3 | psmA3-D-F | CTCAAACATTAACGATCAACAACTC | This study |
psmA3-D-R | GTGAATGGCCCCCTTCAAATAAGAT | This study | |
Deletion of psmα4 | psmA4-D-F | CTCAGGCCACTATACCAATAGG | This study |
psmA4-D-R | CGTTTTGTCCTCCTGTATGTTG | This study | |
psmα1–4 RBS-ORF | PSM-alpha-F | TCTTCTAGACGCACAAGATAACTATGTACAATGAA | This study |
PSM-alpha-R | CTGCTGCAGCAAAGCCACCATCCCTATTG | This study | |
Exchange psmα3 to hld | a-Hld-F | TGGATTATCGACACAGTGAACAAATTCACTAAAAAATAATCTCAAACATTAACGATCAACAAC | This study |
a-Hld-R | TTTTACTAAGTCACCGATTGTTGAAATGATATCTTGTGCCATGTGAATGGCCCCCTTC | This study | |
hld RBS-ORF | hld-F | CTTCTAGAGCATGTTTTAATATAACTAGATCACAG | This study |
hld-R-PstI | CTGCTGCAGCGAAGATAACAAATTTACAATGAAAG | This study | |
agr locus | Fagr-EcoRI | GAAGAATTCTTAAGAGAGCATGAATTTTTAACCG | This study |
Ragr-BamHI | GGAGGATCCGCGTTAATTGATTTTATTCCAAATG | This study |
To obtain S. aureus strains producing low amounts of PSM, the PSM coding sequences were placed under the promoter region of the gmk gene in pND50K [20]. The SD and coding sequence of the hld gene was amplified by PCR using primers (Table 2) and Newman genome DNA as a template, and inserted into pND50K-gmkP, resulting in pWP-δ-toxin. The SD and coding sequences of psmα1, psmα2, psmα3, psmα4, and psmα1–4 were amplified by PCR using primers PSM-alpha-F and PSM-alpha-R (Table 2) and each pSP plasmid as a template, and inserted into pND50K-gmkP, resulting in each pWP plasmid.
RN4220 strain was transformed with plasmids by electroporation and colonies resistant to kanamycin were obtained. Plasmids were transferred to DKO1H1 strain by phage 80α.
Construction of δ-toxin knockout strains of the SA564 and FRP3757 strains
The agr regions carrying wild-type hld gene or two different types of disrupted hld genes were amplified by PCR using oligonucleotide primer pairs (Table 2) and template plasmids (pUC-agr, pUC-agr-hld-frameshift, and pUC-agr-hld-deletion [18]), and inserted into pCK20, resulting in pCK-W, pCK-H1, and pCK-H2 (Table 1). An agr-null strain of RN4220 (CK3) was electroporated with pCK-W, pCK-H1, or pCK-H2, in which the vector was integrated into the original agr locus by a single-crossover homologous recombination, because the adjacent region of the tetM marker in the agr-null strain is homologous to a partial region of the agr region in pCK-W, pCK-H1, and pCK-H2. The desired integration of the vector into chromosome was confirmed by Southern blot analysis. The agr locus carrying wild-type hld gene or two different types of disrupted hld genes in CK3 strain were transferred to SA564 or FRP3757 by transduction using phage 11 or phage 80α, respectively. Phage 11 was isolated from RN451 strain by UV irradiation as reported previously [21]. The desired transfer of the agr locus into SA564 and FRP3757 strains was confirmed by Southern blot analysis.
Colony spreading assay
Colony-spreading activity was examined using the previously described method [9] with minor modifications. In the experiment using Newman strain expressing each PSM, TSB containing 0.24% agar (Nacalai, Kyoto, Japan) was autoclaved at 121°C for 15 min, and 20 ml was poured into φ90 mm x 15 mm dish (GD90-15, AS ONE, Osaka, Japan). The agar plate was dried in a safety cabinet for 15 min and 2 μl of S. aureus overnight culture was spotted onto the center of the plate. The plate was further dried in a safety cabinet for 15 min and incubated at 37°C for 9 h. After incubation, the diameter of the colony was measured. In the experiment using SA564 and FRP3757 strains, 50 ml of the autoclaved TSB containing 0.24% agar was poured into φ150 mm x 15 mm dish (351058, Becton Dickinson, Franklin Lakes, New Jersey). The agar plate was dried in a safety cabinet and 2 μl of S. aureus overnight culture was spotted onto the center of the plate. The plate was further dried in a safety cabinet and incubated at 37°C or 30°C.
Statistical analysis
The correlation coefficient and the p-value were calculated using Microsoft Excel 2011.
Results
PSMα1–4 and δ-toxin are present on the S. aureus cell surface
To reveal the molecular mechanism underlying the opposing colony spreading phenotypes of the PSMα1–4 knockout strain and the δ-toxin knockout strain, the localization and amount of PSM in these mutants must be clarified. Based on a recent report that PSMs are involved in biofilm formation [22], we hypothesized that PSMs are present on the cell surface of S. aureus cells. S. aureus Newman strain cells that were aerobically cultured overnight in TSB medium were washed with milliQ water or chemical reagents that disrupt ionic interactions (5 M NaCl and 3 M LiCl), hydrophobic interactions (2% CHAPS), or hydrogen bonding (8 M urea and 6 M guanidine HCl), and centrifuged. The amounts of PSMα3 or PSMα1+δ-toxin in the centrifuged supernatants were measured. PSMα3 or PSMα1+δ-toxin was recovered from S. aureus cells by reagents other than milliQ water or 5 M NaCl (Fig 1A). When S. aureus cells were disrupted with lysostaphin and treated with 2% CHAPS, the recovered amount of PSM was lower than that recovered by 2% CHAPS only or 6 M guanidine HCl (Fig 1A). Sodium dodecyl sulfate—polyacrylamide gel electrophoresis (SDS-PAGE) analysis revealed that the sample treated with lysostaphin/2%CHAPS contained more protein bands than the samples treated with other reagents (Fig 1B), indicating that lysostaphin/2%CHAPS treatment disrupted S. aureus cells and released cytosolic proteins. These results suggest that the PSM recovered by 2% CHAPS, 8 M urea, 6 M guanidine HCl, or 3 M LiCl derived from the S. aureus cell surface. The lower recovery of PSMs in the lysostaphin /2%CHAPS treatment than in the 2% CHAPS treatment only might be due to the absorbance of PSMs to cytosolic proteins or lipids. Because PSMs form amyloid fibers when S. aureus cells are cultured in a specific media [23], we examined whether the cell surface PSMs detected in this study were amyloid forms. PSMs were recovered by treating S. aureus cells with a detergent solution, 2% SDS (Fig 1C), which does not solubilize amyloid fibers [24, 25]. In this study, we used 6 M guanidine HCl to recover S. aureus cell surface PSMs, because it showed high recovery activity and did little damage to the HPLC column.
To investigate the different functions of PSMα1–4 and δ-toxin, the amount of each respective PSM should be measured. In our previous study to measure PSM by HPLC, PSMα1 and δ-toxin eluted in the same peak and therefore the amount of each could not be measured [19]. Therefore, we developed a new HPLC isocratic elution method using 50% acetonitrile and successfully separated PSMα1 and δ-toxin in the culture supernatant or the cell surface of S. aureus overnight culture (Fig 2A). In the culture supernatant, the amount of δ-toxin was more than that of PSMα1–4 (Fig 2B, right), consistent with a previous report [2]. In contrast, on the cell surface, the ratio of PSMα1–4 to δ-toxin was increased compared with that in the culture supernatant (Fig 2B, left). In 1 ml of S. aureus overnight culture, the total amount of PSMα1–4 was 106 μg and that of δ-toxin was 47.9 μg, and the amount of cell surface PSMα1–4 was 19.0 μg and that of δ-toxin was 4.08 μg, respectively, accounting for 18% and 8.5% of the total amount of PSMα1–4 and δ-toxin, respectively. Because the total volume of cells in 1 ml of overnight culture is very small (~13 μl in our estimate), the local concentration of cell surface PSMα1–4 or cell surface δ-toxin is higher than that in the culture supernatant.
Knockout of δ-toxin increases the amount of cell surface PSMα1–4
To understand the molecular mechanism of the colony-spreading abilities of the PSMα1–4 knockout strain and the δ-toxin knockout strain, we measured the amounts of cell surface and culture supernatant PSMs. In the PSMα1–4 knockout strain, the amount of cell surface δ-toxin did not differ from that in the parent strain, but the amount of culture supernatant δ-toxin was decreased compared with that in the parent strain (Fig 3). The results suggest that PSMα1–4 does not affect the amount of cell surface δ-toxin, but are required to maintain the amount of culture supernatant δ-toxin. The decrease of culture supernatant δ-toxin in the PSMα1–4 knockout strain might be related to the recent finding that the psmα operon encoding PSMα1–4 regulates S. aureus exotoxin production [26].
The δ-toxin is encoded in the hld gene on the agr locus whose mRNA functions as a regulatory RNA called RNAIII [27]. We previously constructed two different δ-toxin knockout strains that carry a partial deletion or a nucleotide insertion in the hld gene, whose RNAIII exhibits function is indistinguishable from the wild-type strain [18] (Fig 4A). In the two δ-toxin knockout strains, the amount of cell surface PSMα1, PSMα2, PSMα3, and PSMα4 was increased compared with the wild-type strain (Fig 4B and 4C, left). Furthermore, in the two δ-toxin knockout strains, the amount of culture supernatant PSMα1, PSMα2, PSMα3, and PSMα4 was decreased compared with that the wild-type strain (Fig 4B and 4C, right). These results suggest that δ-toxin decreases the amount of cell surface PSMα1–4, and increases the amount of culture supernatant PSMα1–4.
δ-toxin inhibits the binding of PSMα2 and PSMα3 to the S. aureus cell surface
Based on the effects of δ-toxin to decrease the amount of cell surface PSMα1–4 and increase the amount of culture supernatant PSMα1–4, we hypothesized that δ-toxin inhibits the binding of PSMα1–4 to the S. aureus cell surface. To examine this further, we established an in vitro binding assay of PSM to the S. aureus cell surface. In this assay, chemically synthesized PSMs were added to the PSMα1-4/δ-toxin double mutant and the amounts of the bound PSMs were measured. PSMα2, PSMα3, and δ-toxin was detected in the centrifuged precipitates dependent on the presence of cells (Fig 5A, 5B and 5C), indicating that PSMα2, PSMα3, and δ-toxin exhibited binding activity to the S. aureus cell surface. The maximum binding amounts of PSMα2 or PSMα3 were 2.3-times or 1.5-times that of δ-toxin (Fig 5D, 5E and 5F). Most of the added PSMα2 and PSMα3 bound to the S. aureus cell surface until the concentration reached maximum binding (Fig 5D and 5E). On the other hand, less than half of the added δ-toxin bound to the S. aureus cell surface (Fig 5F). In this assay system, the solubility of PSMα1 and PSMα4 was low, and thus their binding activity was not examined.
We examined whether δ-toxin inhibits PSMα2 or PSMα3 binding to the S. aureus cell surface. When 10 nmol of PSMα2 was added to S. aureus cells, the addition of a 2-fold molar excess of δ-toxin decreased PSMα2 binding to 25% (Fig 6A, left), and 1.2 nmol of δ-toxin bound to the S. aureus cell surface (Fig 6A, center). Increasing the amount of δ-toxin decreased the total binding amount of PSMα2 and δ-toxin compared with the amount in the absence of δ-toxin (Fig 6A, right). In contrast, when 10 nmol of δ-toxin was added to S. aureus cells, the addition of a 2-fold molar excess of PSMα2 decreased δ-toxin binding to 43% (Fig 6B, left), and 12.3 nmol of PSMα2 bound to the S. aureus cell surface (Fig 6B, center). Increasing the amount of PSMα2 did not decrease the total binding amount of δ-toxin and PSMα2 (Fig 6B, right). When 10 nmol of PSMα3 was added to S. aureus cells, the addition of a 2-fold molar excess of δ-toxin decreased PSMα3 binding to 22% (Fig 6C, left), and 3.1 nmol of δ-toxin bound to the S. aureus cell surface (Fig 6C, center). Increasing the amount of δ-toxin decreased the total PSMα3 and δ-toxin binding amounts (Fig 6C, right). In contrast, when 10 nmol of δ-toxin was added to S. aureus cells, the addition of a 2-fold molar excess of PSMα3 decreased δ-toxin binding to 44% (Fig 6D, left), and 4.4 nmol of PSMα3 bound to the S. aureus cell surface (Fig 6D, center). Increasing the amount of PSMα3 did not decrease the total binding amount of δ-toxin and PSMα3 compared with the total binding amount in the absence of PSMα3 (Fig 6D, right). These results suggest that δ-toxin and PSMα2, or δ-toxin and PSMα3 inhibit the binding of each other to the S. aureus cell surface, but the inhibitory activity of δ-toxin is stronger than that of PSMα2 and PSMα3. Furthermore, when δ-toxin inhibits the binding of PSMα2 or PSMα3, most of the δ-toxin is not bound to the S. aureus cell surface.
Cell surface PSMα1–4 promotes S. aureus colony-spreading activity
Based on the results that the PSMα1–4 knockout strain decreased colony-spreading activity [17], and that the δ-toxin knockout strain with high colony-spreading ability increased the amount of cell surface PSMα1–4 and decreased the amount of culture supernatant PSMα1–4 (Fig 4B and 4C), we hypothesized that cell surface PSMα1–4, not culture supernatant PSMα1–4, promote S. aureus colony spreading. To examine this, we created S. aureus strains expressing different amounts of the PSMs only on the cell surface or on both the cell surface and in the culture supernatant. We utilized two different promoters of the psmα operon [17] or the gmk gene encoding guanylate kinase [20]. Because a luciferase reporter assay revealed that the activity of the psmα promoter was 103-fold or 104-fold higher than that of the gmk promoter at the exponential or stationary phase, we utilized the psmα promoter as a strong promoter and the gmk promoter as a weak promoter. The PSMα1-4/δ-toxin double knockout strain was transformed with a plasmid expressing PSMα1, PSMα2, PSMα3, PSMα4, PSMα1–4, or δ-toxin from the respective promoter, and the amounts of PSMs in the culture supernatant or on the cell surface were measured. We detected all PSMs on the cell surface, irrespective of the use of the strong or weak promoter for PSM expression (Fig 7A). In contrast, in the culture supernatant, when the weak promoter was used for PSM expression, we did not detect any of the PSMs (Fig 7B). In the culture supernatant, when the strong promoter was used for PSM expression, we detected PSMα3, PSMα4, PSMα1–4, and δ-toxin, but not PSMα1 or PSMα2 (Fig 7B). Therefore, use of the weak promoter enabled the construction of S. aureus strains possessing cell surface PSMs, but not culture supernatant PSMs.
We examined the colony-spreading abilities of S. aureus strains expressing different PSMs with different localization. The PSMα1-4/δ-toxin double knockout strain exhibited decreased colony-spreading ability compared with the parent strain (Fig 8A and 8B). The double knockout strain transformed with pSP-PSMα1–4 expressing PSMα1–4 from the strong promoter exhibited colony-spreading ability comparable to that of the parent strain, although the colony morphology differed from that of the parent strain (Fig 8A and 8B). Furthermore, the double knockout strain transformed with pWP-PSMα1–4 expressing PSMα1–4 from the weak promoter exhibited higher colony-spreading ability than the parent strain or the double knockout strain transformed with pSP-PSMα1–4 expressing PSMα1–4 from the strong promoter (Fig 8A and 8B). These results suggest that cell surface PSMα1–4, but not culture supernatant PSMα1–4, promote S. aureus colony-spreading activity. In addition, culture supernatant PSMα1–4 inhibit S. aureus colony spreading. In contrast, the double knockout strain transformed with pSP-δ-toxin or pWP-δ-toxin, which expresses δ-toxin from the strong promoter or the weak promoter, did not restore the colony-spreading ability (Fig 8A and 8B). The findings suggest that δ-toxin is not involved in promoting S. aureus colony-spreading activity. Furthermore, the double knockout strain transformed with pSP-PSMα1, pSP-PSMα2, pWP-PSMα3, or pWP-PSMα4, in which a single species of PSMα exists on the cell surface, but not in the culture supernatant, restored colony-spreading ability (Figs 7 and 8). The colony-spreading ability of these strains was weaker than that of the double knockout strain transformed with pWP-PSMα1–4, in which PSMα1–4 exists on the cell surface (Fig 8B). These results suggest that the single species of cell surface PSMα was not sufficient for the promotion of colony spreading, but cell surface PSMα1, PSMα2, PSMα3, and PSMα4 additively promoted colony spreading.
Role of δ-toxin in S. aureus strains other than Newman
S. aureus has a high genetic variation associated with different strain phenotypes, in which the effect of gene knockout is sometimes different between S. aureus strains. We examined whether the observed effect of δ-toxin knockout in Newman strain is conserved in other S. aureus strains, i.e., SA564 and FRP3757 (USA300). We constructed δ-toxin knockout strains in SA564 and FRP3757 strains (Fig 9A). First, we examined whether the δ-toxin-mediated release of PSMα1–4 is observed in SA564 and FRP3757 strains. In the δ-toxin knockout strains of the SA564 and FRP3757 strains, the amounts of cell surface PSMα2 and PSMα3, but not PSMα1 and PSMα4, were increased compared with that in the wild-type strain (Fig 9B and 9C, left graphs). In contrast, the amounts of culture supernatant PSMα1–4 were decreased compared with that in the wild-type strain (Fig 9B and 9C, right graphs). Thus, the function of δ-toxin to release PSMα1–4 from cell surface is conserved among the Newman, SA564, and FRP3757 strains. Next, we examined whether the inhibitory function of δ-toxin against S. aureus colony spreading is conserved in the SA564 and FRP3757 strains. In the SA564 strain, the δ-toxin knockout strains showed higher colony-spreading activities than the wild-type strain (Fig 10A and 10B). In the FRP3757 strain, the δ-toxin knockout strains exhibited higher colony-spreading activities than the wild-type strain at 30°C, but not at 37°C (Fig 10A and 10B). These results suggest that the inhibitory function of δ-toxin against colony spreading is conserved among the Newman, SA564, and FRP3757 strains.
Relationship between the amounts of cell surface PSMs and colony-spreading activity
To determine whether the amount of cell surface PSMs explains the difference in the colony-spreading activity among S. aureus strains, we compared the amount of cell surface PSMs and the colony-spreading activity of 55 S. aureus strains, including 40 HA-MRSA strains, 14 CA-MRSA strains, and Newman strain. To simplify the measurement, the amount of PSMα4 was not included in the analysis. The correlation coefficient between the amount of cell surface PSMα1–3 and colony-spreading activity was 0.591 (Fig 11A). In contrast, the correlation coefficient between the amount of cell surface δ-toxin and colony-spreading activity was 0.172 (Fig 11B). These results suggest that the amount of cell surface PSMα1–3, not cell surface δ-toxin, is positively related to the colony-spreading activity of each S. aureus strain. The Newman strain had the highest amount of cell surface PSMα1–3 among the examined strains (Fig 11A), which might be one reason for its strong colony-spreading activity.
Discussion
The findings of the present study revealed the existence of PSMs on the S. aureus cell surface. We demonstrated that knocking out δ-toxin increases the amount of cell surface PSMα1–4, and decreases the amount of culture supernatant PSMα1–4. An in vitro binding assay revealed that δ-toxin inhibits the binding of PSMα2 or PSMα3 to the S. aureus cell surface. Furthermore, S. aureus strains expressing cell surface PSMα1–4, but not culture supernatant PSMα1–4, exhibited strong colony-spreading activity, indicating that cell surface PSMα1–4, but not culture supernatant PSMα1–4, promote colony spreading. These findings suggest that the decreased colony-spreading ability of the PSMα1–4 knockout strain is due to the absence of cell surface PSMα1–4, and the increased colony-spreading ability of the δ-toxin knockout strain is due to an increase in the cell surface PSMα1–4 (Fig 12). This study unveiled the molecular mechanism underlying the opposing roles of PSMα1–4 and δ-toxin in S. aureus colony spreading as the regulation of the amount of cell surface PSMα1–4.
This study further examined the conservation of δ-toxin function among different S. aureus strains. The function of δ-toxin to release PSMα1–4 from S. aureus cell surface as well as the inhibitory function of δ-toxin against colony spreading was conserved among the Newman, SA564, and FRP3757 strains. Curiously, in the δ-toxin knockout strains of SA564 and FRP3757, the amount of PSMα1 and PSMα4 was not increased on the S. aureus cell surface, but was decreased in culture supernatants. It is possible that δ-toxin knockout leads to excess accumulation of PSMα1 and PSMα4, resulting the production of amyloid fibers in these strains. In addition, in FRP3757 strain, the inhibitory function of δ-toxin against colony spreading was not observed at 37°C, but was observed at 30°C. The result indicates that the FRP3757 strain has some mechanism(s) to mask the inhibitory effect of δ-toxin against colony spreading at 37°C. These strain-specific effects of δ-toxin should be examined in a future study.
In this study, we performed a correlation analysis between the amounts of cell surface PSMs and the colony-spreading activity in S. aureus clinical isolates and revealed a positive correlation between the amount of cell surface PSMα1–3 and colony-spreading activity (r = 0.591), but the lack of a correlation between the amount of cell surface δ-toxin and colony-spreading activity (r = 0.172). The results suggest that the colony spreading activity of each S. aureus strain is positively determined by the amount of cell surface PSMα1–3, but not by the amount of cell surface δ-toxin. The correlation coefficient between the amount of cell surface PSMα1–3 and the colony-spreading activity was not high, indicating that the colony-spreading activity of each S. aureus strain is determined not only by cell surface PSMα1–3, but also by other factors, such as secreted nucleases [20], teichoic acids [9], and catabolite regulators [13], which may differ from strain to strain.
Recently, Tsompanidou et al. demonstrated that the agr-null strain of S. aureus restores colony-spreading ability when chemically synthesized PSMα3 or δ-toxin is spotted onto the surface of soft agar plates [16]. Furthermore, the solution of PSMα3 or δ-toxin spread on the surface of soft agar plates [16]. Based on these observations, Tsompanidou et al. suggested that PSMα3 and δ-toxin secreted from S. aureus cells into the culture supernatant promote colony spreading as surfactants and reasoned that the defective colony-spreading activity of the agr-null mutant is due to the absence of PSMα3 and δ-toxin in the culture supernatant [16]. Their theory, however, does not explain the finding that the δ-toxin knockout strain exhibits increased colony-spreading ability compared with the parent strain [18]. Recently, Cheung et al. reported similar data indicating that δ-toxin expression decreases colony spreading [28]. Placing a PSM solution on the surface of soft agar plates may not reflect the status of PSM produced by S. aureus cells. Furthermore, we revealed that an S. aureus strain expressing both culture supernatant and cell surface PSMα1–4 exhibited less colony-spreading activity than the strain expressing cell surface PSMα1–4 only, indicating that culture supernatant PSMα1–4 is not stimulatory, but rather inhibitory, against colony spreading. This observation is consistent with our previous observation that serum lipoprotein promotes S. aureus colony spreading [15] and a report that serum lipoprotein absorbs S. aureus PSMs [29], because the absorption of culture supernatant PSMs by serum lipoprotein would promote S. aureus colony-spreading activity. Recently, it was suggested that the released PSM, which is present in the halo around the S. aureus giant colony [16], contributes to avoid other bacterial colonies and to form the dendritic morphology of the giant colony [30]. Further studies are needed to reveal the physiologic role of the released PSM for S. aureus colony spreading.
In the in vitro binding assay of PSM against the S. aureus cell surface, PSMα2, PSMα3, and δ-toxin exhibited binding activity against the S. aureus cell surface. The solubility of chemically synthesized PSMα1 and PSMα4 was too low to examine the binding activity. In contrast, the PSMα1-4/δ-toxin double knockout strain transformed with plasmids expressing PSMα1 or PSMα4 expressed cell-surface PSMα1 or PSMα4 (Fig 5A). In the physiologic condition that S. aureus cells synthesize and secrete these proteins into the extracellular milieu, some molecules may increase the solubility of PSMα1 and PSMα4 and stabilize the binding of PSMα1 and PSMα4 to the S. aureus cell surface.
The binding of PSMα2 or PSMα3 to the S. aureus cell surface was inhibited to below 25% by the addition of a 2-fold molar excess of δ-toxin, but the binding of δ-toxin to the S. aureus cell surface was inhibited to ~40% by the addition of 2-fold molar excess of PSMα2 or PSMα3. Because the total amount of δ-toxin in S. aureus overnight culture is more than that of PSMα2 or PSMα3, the inhibitory effect of δ-toxin on the binding of PSMα2 and PSMα3 to the S. aureus cell surface would be predominant. In addition, the PSM-to-S. aureus cell surface binding assay revealed that the maximum amount of PSMα2 or PSMα3 binding to the S. aureus cell surface was greater than that of δ-toxin, indicating that there were more PSMα2 or PSMα3 binding sites than δ-toxin binding sites. Binding of PSMα2, PSMα3, or δ-toxin was observed at almost the same concentrations, indicating that the binding affinities of PSMα2, PSMα3, and δ-toxin are similar. These observations indicate that δ-toxin inhibits the binding of PSMα2 or PSMα3 to the S. aureus cell surface, despite fewer binding sites for δ-toxin than PSMα2 or PSMα3, as well as indistinguishable binding affinities among PSMα2, PSMα3, and δ-toxin. When δ-toxin inhibits the binding of PSMα2 or PSMα3 to the S. aureus cell surface, only a small part of the added δ-toxin bound to the S. aureus cell surface. Therefore, we assume that δ-toxin inhibits the binding of PSMα2 or PSMα3 to S. aureus, not by occupying the binding sites of PSMα2 or PSMα3, but rather by forming a complex with PSMα2 or PSMα3, thereby inhibiting the binding activity. Because δ-toxin forms a complex comprising more than 100 molecules at a high concentration [31], such a large complex of δ-toxin with hydrophobic properties may absorb PSMα2 or PSMα3.
This study revealed that colony-spreading activity is not promoted by cell surface δ-toxin, but is promoted by cell surface PSMα1, PSMα2, PSMα3, and PSMα4. The surfactant activity of δ-toxin is almost the same as that of PSMα3 and higher than that of PSMα1, PSMα2, and PSMα4 [16]. Therefore, the surfactant properties of these PSM peptides are not correlated with their promotion of colony spreading, and do not explain the roles of PSM peptides in colony spreading. In contrast, the charges of PSMα1, PSMα2, PSMα3, PSMα4, and δ-toxin are +1, +2, +1, +1, and 0 [3]. Thus, the charges of the PSM peptides are well correlated with their promotion of colony spreading. Considering the differences in the charges, the target molecules of PSMα1, PSMα2, PSMα3, and PSMα4 on the S. aureus cell surface may differ from that of δ-toxin, and the binding of PSMα1–4 to the target molecules may alter the interactions between S. aureus cells to promote colony spreading. A recent intriguing study suggested that S. aureus colony-spreading occurs by absorbing water from soft agar plates and floating on the water [32]. The cell surface PSMα1–4 might be important in the process of absorbing water. Additional studies are needed to identify the target molecules of PSMα1–4 and δ-toxin on the S. aureus cell surface and to further develop our understanding of PSMs—multi-functional peptides in the S. aureus infection process.
Acknowledgments
We thank D. Nakane for helpful discussions and R. Novick for providing the RN451 strain.
Data Availability
All relevant data are within the paper.
Funding Statement
This work was supported by Grants-in-Aid for Scientific Research to CK (25117507, 15H04727, 15H05783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557–68. Epub 2010/03/09. 10.1016/S0140-6736(09)61999-1 S0140-6736(09)61999-1 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med. 2007;13(12):1510–4. 10.1038/nm1656 . [DOI] [PubMed] [Google Scholar]
- 3.Peschel A, Otto M. Phenol-soluble modulins and staphylococcal infection. Nat Rev Microbiol. 2013;11(10):667–73. Epub 2013/09/11. 10.1038/nrmicro3110 nrmicro3110 [pii]. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kretschmer D, Gleske AK, Rautenberg M, Wang R, Koberle M, Bohn E, et al. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe. 2010;7(6):463–73. Epub 2010/06/15. 10.1016/j.chom.2010.05.012 S1931-3128(10)00175-7 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Munoz-Planillo R, Hasegawa M, et al. Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503(7476):397–401. Epub 2013/11/01. 10.1038/nature12655 nature12655 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cogen AL, Yamasaki K, Sanchez KM, Dorschner RA, Lai Y, MacLeod DT, et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol. 2010;130(1):192–200. Epub 2009/08/28. 10.1038/jid.2009.243 jid2009243 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Joo HS, Cheung GY, Otto M. Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem. 2011;286(11):8933–40. Epub 2011/02/01. 10.1074/jbc.M111.221382 M111.221382 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Periasamy S, Joo HS, Duong AC, Bach TH, Tan VY, Chatterjee SS, et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci U S A. 2012;109(4):1281–6. Epub 2012/01/11. 10.1073/pnas.1115006109 1115006109 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kaito C, Sekimizu K. Colony spreading in Staphylococcus aureus. J Bacteriol. 2007;189(6):2553–7. 10.1128/JB.01635-06 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kaito C, Omae Y, Matsumoto Y, Nagata M, Yamaguchi H, Aoto T, et al. A novel gene, fudoh, in the SCCmec region suppresses the colony spreading ability and virulence of Staphylococcus aureus. PLoS ONE. 2008;3(12):e3921 10.1371/journal.pone.0003921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kaito C, Saito Y, Ikuo M, Omae Y, Mao H, Nagano G, et al. Mobile genetic element SCCmec-encoded psm-mec RNA suppresses translation of agrA and attenuates MRSA virulence. PLoS Pathog. 2013;9(4):e1003269 Epub 2013/04/18. 10.1371/journal.ppat.1003269 PPATHOGENS-D-12-02302 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Aoyagi T, Kaito C, Sekimizu K, Omae Y, Saito Y, Mao H, et al. Impact of psm-mec in the mobile genetic element on the clinical characteristics and outcome of SCCmec-II methicillin-resistant Staphylococcus aureus bacteraemia in Japan. Clin Microbiol Infect. 2014;20(9):912–9. Epub 2014/01/31. 10.1111/1469-0691.12575 S1198-743X(14)65099-0 [pii]. . [DOI] [PubMed] [Google Scholar]
- 13.Ueda T, Kaito C, Omae Y, Sekimizu K. Sugar-responsive gene expression and the agr system are required for colony spreading in Staphylococcus aureus. Microb Pathog. 2011;51(3):178–85. Epub 2011/04/26. S0882-4010(11)00067-2 [pii] 10.1016/j.micpath.2011.04.003 . [DOI] [PubMed] [Google Scholar]
- 14.Tsompanidou E, Sibbald MJ, Chlebowicz MA, Dreisbach A, Back JW, van Dijl JM, et al. Requirement of the agr locus for colony spreading of Staphylococcus aureus. J Bacteriol. 2011;193(5):1267–72. Epub 2010/12/21. JB.01276-10 [pii] 10.1128/JB.01276-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Omae Y, Sekimizu K, Kaito C. Identification of Staphylococcus aureus colony-spreading stimulatory factors from mammalian serum. PLoS ONE. 2014;9(5):e97670 Epub 2014/05/17. 10.1371/journal.pone.0097670 PONE-D-14-12088 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Tsompanidou E, Denham EL, Becher D, de Jong A, Buist G, van Oosten M, et al. Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces. Appl Environ Microbiol. 2013;79(3):886–95. Epub 2012/11/28. 10.1128/AEM.03157-12 AEM.03157-12 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kaito C, Saito Y, Nagano G, Ikuo M, Omae Y, Hanada Y, et al. Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS pathogens. 2011;7(2):e1001267 Epub February 3, 2011. 10.1371/journal.ppat.1001267 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Omae Y, Sekimizu K, Kaito C. Inhibition of colony-spreading activity of Staphylococcus aureus by secretion of delta-hemolysin. J Biol Chem. 2012;287(19):15570–9. Epub 2012/03/14. M112.357848 [pii] 10.1074/jbc.M112.357848 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Yoshikai H, Kizaki H, Saito Y, Omae Y, Sekimizu K, Kaito C. Multidrug-Resistance Transporter AbcA Secretes Staphylococcus aureus Cytolytic Toxins. J Infect Dis. 2016;213(2):295–304. Epub 2015/07/15. 10.1093/infdis/jiv376 jiv376 [pii]. . [DOI] [PubMed] [Google Scholar]
- 20.Kaito C, Hirano T, Omae Y, Sekimizu K. Digestion of extracellular DNA is required for giant colony formation of Staphylococcus aureus. Microb Pathog. 2011;51(3):142–8. Epub 2011/05/05. S0882-4010(11)00080-5 [pii] 10.1016/j.micpath.2011.04.007 . [DOI] [PubMed] [Google Scholar]
- 21.Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967;33(1):155–66. Epub 1967/09/01. 0042-6822(67)90105-5 [pii]. 10.1016/0042-6822(67)90105-5 . [DOI] [PubMed] [Google Scholar]
- 22.Dastgheyb SS, Villaruz AE, Le KY, Tan VY, Duong AC, Chatterjee SS, et al. Role of Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid. Infect Immun. 2015;83(7):2966–75. Epub 2015/05/13. 10.1128/IAI.00394-15 IAI.00394-15 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog. 2012;8(6):e1002744 Epub 2012/06/12. 10.1371/journal.ppat.1002744 PPATHOGENS-D-12-00201 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Collinson SK, Emody L, Muller KH, Trust TJ, Kay WW. Purification and characterization of thin, aggregative fimbriae from Salmonella enteritidis. J Bacteriol. 1991;173(15):4773–81. Epub 1991/08/01. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science. 2002;295(5556):851–5. Epub 2002/02/02. 10.1126/science.1067484 295/5556/851 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Berube BJ, Sampedro GR, Otto M, Bubeck Wardenburg J. The psmalpha locus regulates production of Staphylococcus aureus alpha-toxin during infection. Infect Immun. 2014;82(8):3350–8. Epub 2014/05/29. 10.1128/IAI.00089-14 IAI.00089-14 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 1993;12(10):3967–75. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cheung GY, Yeh AJ, Kretschmer D, Duong AC, Tuffuor K, Fu CL, et al. Functional characteristics of the Staphylococcus aureus delta-toxin allelic variant G10S. Sci Rep. 2015;5:18023 Epub 2015/12/15. 10.1038/srep18023 srep18023 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Surewaard BG, Nijland R, Spaan AN, Kruijtzer JA, de Haas CJ, van Strijp JA. Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog. 2012;8(3):e1002606 Epub 2012/03/30. 10.1371/journal.ppat.1002606 PPATHOGENS-D-11-02500 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pollitt EJ, Crusz SA, Diggle SP. Staphylococcus aureus forms spreading dendrites that have characteristics of active motility. Sci Rep. 2015;5:17698 Epub 2015/12/19. 10.1038/srep17698 srep17698 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Thiaudiere E, Siffert O, Talbot JC, Bolard J, Alouf JE, Dufourcq J. The amphiphilic alpha-helix concept. Consequences on the structure of staphylococcal delta-toxin in solution and bound to lipids. Eur J Biochem. 1991;195(1):203–13. Epub 1991/01/01. 10.1111/j.1432-1033.1991.tb15696.x . [DOI] [PubMed] [Google Scholar]
- 32.Lin MH, Ke WJ, Liu CC, Yang MW. Modulation of Staphylococcus aureus spreading by water. Sci Rep. 2016;6:25233 Epub 2016/04/30. 10.1038/srep25233 srep25233 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Duthie ES, Lorenz LL. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol. 1952;6(1–2):95–107. 10.1099/00221287-6-1-2-95 . [DOI] [PubMed] [Google Scholar]
- 34.Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol. 1988;170(9):4365–72. . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Matsumoto Y, Kaito C, Morishita D, Kurokawa K, Sekimizu K. Regulation of exoprotein gene expression by the Staphylococcus aureus cvfB gene. Infect Immun. 2007;75(4):1964–72. 10.1128/IAI.01552-06 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Somerville GA, Beres SB, Fitzgerald JR, DeLeo FR, Cole RL, Hoff JS, et al. In vitro serial passage of Staphylococcus aureus: changes in physiology, virulence factor production, and agr nucleotide sequence. J Bacteriol. 2002;184(5):1430–7. Epub 2002/02/15. 10.1128/JB.184.5.1430-1437.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006;367(9512):731–9. 10.1016/S0140-6736(06)68231-7 . [DOI] [PubMed] [Google Scholar]
- 38.Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin Infect Dis. 2001;33(7):990–6. 10.1086/322693 . [DOI] [PubMed] [Google Scholar]
- 39.Daum RS, Ito T, Hiramatsu K, Hussain F, Mongkolrattanothai K, Jamklang M, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis. 2002;186(9):1344–7. Epub 2002/10/29. JID020570 [pii] 10.1086/344326 . [DOI] [PubMed] [Google Scholar]
- 40.Ichihashi N, Kurokawa K, Matsuo M, Kaito C, Sekimizu K. Inhibitory effects of basic or neutral phospholipid on acidic phospholipid-mediated dissociation of adenine nucleotide bound to DnaA protein, the initiator of chromosomal DNA replication. J Biol Chem. 2003;278(31):28778–86. 10.1074/jbc.M212202200 . [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All relevant data are within the paper.